Chasing the moon
PBS just dropped the third in this series. Each is an almost 2hr documentary. Very well done, with a lot of original clips and interviews.
PBS just dropped the third in this series. Each is an almost 2hr documentary. Very well done, with a lot of original clips and interviews.
Waiting on approval letter for my Nintedanib (Ofev generic). I received a call today confirming approval.
I'm diagnosed with SSC-ILD (Systemic Sclerosis Interstitial Lung Disease).
I already taking mycophenolate mofetil. And then I lookup the mechanism of Nintedanib, and find this article:
| **Dr. Scofield Prescribes** As its name suggests, type 1.5 diabetes – now known as latent autoimmune diabetes (LADA) – is a form of the disease that shares characteristics with both type 1 and type 2 diabetes. |
|---|
| Let’s start with a quick overview of the two types of diabetes people know best. Type 1 is an autoimmune disease that most often takes hold in childhood. Type 2 more typically develops later in life, usually due to a combination of factors like genetics, excess weight, physical inactivity and age. Both of these forms of diabetes are marked by problems with insulin, a hormone that turns food into energy. In both, your body can’t make enough insulin or can’t use it properly. This leads to high blood sugar, which can require lifelong insulin treatments. LADA is a slowly progressing form of autoimmune diabetes. It develops when the body’s immune system mistakenly begins attacking the cells that produce insulin. So, in this way, it is like type 1 diabetes. However, the disease usually develops in adulthood, most commonly over the age of 30. This later onset is a characteristic LADA shares with type 2 diabetes. And like type 2, LADA progresses slowly. As a result, physicians often mistake LADA for type 2 diabetes. An estimated 4-14% of patients diagnosed with type 2 diabetes may actually have LADA. So, what does this mean? If LADA is misdiagnosed as type 2 diabetes, doctors frequently start patients on non-insulin treatments. And while these approaches – which include the drug metformin, various inhibitors, and GLP-1 drugs like Ozempic and Mounjaro – can be effective for type 2 diabetes, they don’t help people with LADA. For LADA, the course of treatment mirrors that for type 1 diabetes: beginning low-dose insulin injections and controlling blood sugar through diet and exercise. And like type 1 diabetes, LADA requires this therapeutic regimen to continue throughout a patient’s life. If a person starts showing symptoms of diabetes later in life – excessive thirst, frequent urination, unexplained weight loss – chances are it’s type 2. However, it could be LADA. Some of the telltale clues are what’s *not* there: high blood pressure, excess weight, a family history of type 2 diabetes, a response to non-insulin drugs. If some or all of these factors are missing, LADA may be the answer. |
|---|
| *Adam Cohen is OMRF’s senior vice president and general counsel. Dr. Hal Scofield is a physician-scientist at the Oklahoma Medical Research Foundation, and he also serves as Associate Chief of Staff for Research at the Oklahoma City VA Medical Center. Email us at* [*contact@omrf.org*](mailto:contact@omrf.org) *to send a health query!* |
|---|
I received this in an e-mail from OMRF. (Oklahoma Medical Research Foundation)
I thought that some in the community could use this information.
| Dr. Scofield Prescribes As its name suggests, type 1.5 diabetes – now known as latent autoimmune diabetes (LADA) – is a form of the disease that shares characteristics with both type 1 and type 2 diabetes. |
|---|
| Let’s start with a quick overview of the two types of diabetes people know best. Type 1 is an autoimmune disease that most often takes hold in childhood. Type 2 more typically develops later in life, usually due to a combination of factors like genetics, excess weight, physical inactivity and age. Both of these forms of diabetes are marked by problems with insulin, a hormone that turns food into energy. In both, your body can’t make enough insulin or can’t use it properly. This leads to high blood sugar, which can require lifelong insulin treatments. LADA is a slowly progressing form of autoimmune diabetes. It develops when the body’s immune system mistakenly begins attacking the cells that produce insulin. So, in this way, it is like type 1 diabetes. However, the disease usually develops in adulthood, most commonly over the age of 30. This later onset is a characteristic LADA shares with type 2 diabetes. And like type 2, LADA progresses slowly. As a result, physicians often mistake LADA for type 2 diabetes. An estimated 4-14% of patients diagnosed with type 2 diabetes may actually have LADA. So, what does this mean? If LADA is misdiagnosed as type 2 diabetes, doctors frequently start patients on non-insulin treatments. And while these approaches – which include the drug metformin, various inhibitors, and GLP-1 drugs like Ozempic and Mounjaro – can be effective for type 2 diabetes, they don’t help people with LADA. For LADA, the course of treatment mirrors that for type 1 diabetes: beginning low-dose insulin injections and controlling blood sugar through diet and exercise. And like type 1 diabetes, LADA requires this therapeutic regimen to continue throughout a patient’s life. If a person starts showing symptoms of diabetes later in life – excessive thirst, frequent urination, unexplained weight loss – chances are it’s type 2. However, it could be LADA. Some of the telltale clues are what’s not there: high blood pressure, excess weight, a family history of type 2 diabetes, a response to non-insulin drugs. If some or all of these factors are missing, LADA may be the answer. |
|---|
| Adam Cohen is OMRF’s senior vice president and general counsel. Dr. Hal Scofield is a physician-scientist at the Oklahoma Medical Research Foundation, and he also serves as Associate Chief of Staff for Research at the Oklahoma City VA Medical Center. Email us at contact@omrf.org to send a health query! |
|---|
I received this in an e-mail from OMRF. (Oklahoma Medical Research Foundation)
I thought that some in the community could use this information.
Saw a new Pulmonologist today. Previous moved back to a practice he was in before.
Anyway, in two days when my pharm gets in stock, I'll be starting Nintedanib Esylate 150 MG twice per day. I was told it will severely loosen my bowels at least for a while, but will also slow my lung damage. It isn't cheap, and I get to pay 30% since it is tier 5 specialty drug on my Medicare Advantage plan. Brand name: Ofev
Great movie, with a good simple plot.
I've definitely have pulmonary scleroderma, I've 55% remaining of my lung capacity.
Additionally I've developed a thickened patch near my left elbow. But that same elbow is uncomfortable near maximum flex. For those with more extensive scleroderma, could the patch and discomfort be related?
No more. I just changed oil on my 2017 GT 2.5L, and found the filter was missing the first threads on the outside edge. It could not screw on. I had to go out and get a Purolator instead.
Just wanted to share with those trying to take care of their own car.
My wife and I enjoyed it very much, although the ending wasn't complete. You don't have to be a sci-fi fan to enjoy it.